Investment
Features
FeesSafety
Academy
More
Pluang+

Federal Signal reports 19% sales growth and raises 2026 outlook on strong Q2 results

Company Fundamentals
30 Jul 2026
PRNewsWire
View Source
Bullish
Federal Signal reports 19% sales growth and raises 2026 outlook on strong Q2 results

Federal Signal Corporation reported a 19% increase in net sales to $670 million for Q2 2026, with operating income up 21% to $118.2 million. The company raised its full-year 2026 net sales outlook to $2.58-$2.67 billion and adjusted EPS forecast to $5.12-$5.30, reflecting strong demand and improved margins. Operating cash flow nearly doubled to $113 million, providing financial flexibility for growth and shareholder returns. These results highlight the company's robust business model and growth momentum across its Environmental Solutions and Safety and Security Systems segments.

More News

UNFI Q4 revenue dips 1.6% but EPS rebounds to $0.61-$0.62, signaling strong profit recovery

UNFI Q4 revenue dips 1.6% but EPS rebounds to $0.61-$0.62, signaling strong profit recovery

United Natural Foods (UNFI) is set to report Q4 earnings with revenue expected around $7.71 billion, a slight 1.6% decline from last year due to network optimization. Despite the revenue drop, EPS is forecasted to rise sharply to $0.61-$0.62, a signi...

Company Fundamentals
Bullish
1 hour ago
Oracle's strong financials and AI investments boost analyst price target by 36%.

Oracle's strong financials and AI investments boost analyst price target by 36%.

Oracle reported strong fiscal 2026 results with 17% revenue growth to $67 billion and a 36% net income increase, driven by a 75% surge in its cloud infrastructure segment. Despite a recent 55% stock price drop from its peak, Morgan Stanley raised Ora...

Analyst Insights
Bullish
2 hours ago
RBC Capital raises Zscaler price target to $210 on strong revenue growth and AI-driven innovation.

RBC Capital raises Zscaler price target to $210 on strong revenue growth and AI-driven innovation.

RBC Capital increased its price target for cybersecurity firm Zscaler to $210, maintaining an "Outperform" rating due to the company's strong financial results and AI innovation. Zscaler reported a 25% rise in revenue and Annual Recurring Revenue, su...

Analyst Insights
Bullish
2 hours ago
Lululemon shares drop 18% as company cuts full-year forecast amid sales decline.

Lululemon shares drop 18% as company cuts full-year forecast amid sales decline.

Lululemon Athletica's shares fell about 18% after the company lowered its full-year financial forecast for the second time, reflecting ongoing challenges. In Q2 2026, total net revenue dropped 4% to $2.40 billion, with a 10% fall in comparable sales ...

Company Fundamentals
Bearish
3 hours ago
Teva gains bullish momentum after positive celiac disease trial and UBS upgrades price target to $48

Teva gains bullish momentum after positive celiac disease trial and UBS upgrades price target to $48

Teva Pharmaceutical Industries received a boost as UBS reaffirmed its "Buy" rating and raised the price target to $48, up from $36.62. This follows positive Phase 2a clinical trial results for TEV '408, a drug showing significant prevention of intest...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App